Targeted for Corporate Purchasing Managers, Technical Directors and Operations Leaders, our dual‑action HIV therapeutic platform eliminates the high‑price, low‑quality, and slow‑delivery bottlenecks that plague today’s supply chain.
In 2025, 34 % of procurement teams reported that *high price* and *slow delivery* of HIV APIs caused project delays, eroding market share. Below are the six most common pain points you encounter every quarter:
Imagine a scenario where your next batch arrives in 2 weeks, at 30 % lower cost, with full GMP, FDA, and ISO‑9001 certification, and backed by a dedicated technical team. That’s the competitive edge you need.
| Parameter | HIV Fusion Inhibitor (e.g., Enfuvirtide‑Analog) | Protease Inhibitor (e.g., Darunavir‑Base) |
|---|---|---|
| Molecular Weight (g/mol) | 4,750 | 700 |
| Purity (HPLC) | ≥ 99.8 % | ≥ 99.9 % |
| Moisture Content | ≤ 0.5 % | ≤ 0.2 % |
| Batch Size | 100 g – 5 tonnes | 200 g – 8 tonnes |
| Certificate | FDA DMF, GMP, ISO 9001 | EMA GMP, CE‑Mark, ISO 9001 |
Scenario 1 – Late‑Stage Clinical Trial Acceleration
Dejuru Pharmaceutical needed 1 tonne of a next‑generation protease inhibitor within 30 days. Global Technology mobilized a dedicated line, delivering 1.02 tonnes in 16 days, cutting trial start‑up time by 45 % and saving $1.2 M in logistics.
Scenario 2 – Generic Formulation Development
A U.S. biotech firm required a custom‑salt fusion inhibitor for a pediatric formulation. Our ODM team provided a 99.9 % pure API with particle size < 10 µm, enabling a stable oral suspension and reducing formulation cycles from 8 weeks to 3 weeks.
Bulk-Enfuvirtide-Acetate-for-anti-HIV-drug-production CAS-136058-54-3-Maraviroc HBV-Core14-HBA31-peptide-antigen-supplier Antiviral-screening-reagent-supplier
The MOQ is 100 g for research‑grade material and 5 kg for GMP‑grade production. Larger volumes receive volume‑based discounts.
Yes. We supply FDA‑registered DMF, EMA GMP certificates, CE‑Mark technical files, and full analytical data packages upon request.
Standard terms are 30 % T/T in advance, 70 % against copy of BL. For qualified accounts we can extend to 60 days after receipt of goods.

Absolutely. Our R&D team can develop custom salts, micronized particles, or co‑crystals within 3‑4 weeks, with full analytical validation.
Standard air freight: 7‑10 business days (door‑to‑door). Express service: 48‑hour dispatch from production completion.
Dedicated technical account manager, free stability data for the first year, and a 12‑month guarantee against out‑of‑spec batches.
Limited‑time Offer: Place an order before 31 May 2026 and receive a free 200 g sample plus a money‑back guarantee if the batch does not meet the quoted specifications.
All communications are encrypted and comply with GDPR, CCPA, and HIPAA where applicable.
James O’Neil, Procurement Lead – NovaPharm (USA) – “The price was 28 % lower than our previous Chinese supplier, and the batch passed QC on first attempt. Delivery was 2 weeks ahead of schedule.”
Laura Kim, Technical Director – Helix Biotech – “Their OEM service let us create a pediatric‑friendly salt form in record time. The regulatory package was complete and accepted by the FDA without additional queries.”
Raj Patel, Operations Manager – MedGlobal (UK) – “We appreciated the 48‑hour express shipping for a critical clinical trial. The sample quality was flawless – a true partnership experience.”
Global Technology Co., Ltd – No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Visit our Contact Page for a personalized quotation.
Trusted by Leading Pharma & Biotech Brands
What Our Clients Say
“Global Technology delivered 2 tonnes of protease inhibitor in 12 days. Our trial costs dropped by 38 % and we met the FDA filing deadline with zero hiccups.”
“The price quote was transparent, and the final landed cost was 27 % lower than our previous Chinese supplier. Quality was verified on the first batch – no re‑testing needed.”
“Their OEM capability allowed us to develop a pediatric‑friendly fusion inhibitor with a custom salt form, accelerating our IND submission by 6 weeks.”
Compliance & Certifications